Emergent Biosolutions Inc (NYSE: EBS) Plunges -0.46% And Its 13.54% Stock Volatility Is Bewildering

Emergent Biosolutions Inc (NYSE:EBS) does about 6.08M shares in volume on a normal day but saw 1380598 shares change hands in Friday’s trading. The company now has a market cap of 227.94M USD. Its current market price is $4.35, marking a decrease of -0.46% compared to the previous close of $4.37. The 52 week high reached by this stock is $10.88 whilst the lowest price level in 52 weeks is $1.42.

Emergent Biosolutions Inc (EBS) has a 20-day trading average at $2.73 and the current price is -60.02% off the 52-week high compared with 206.34% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.61 and its 200-day simple moving average is $2.95. If we look at the stock’s price movements over the week, volatility stands at 13.54%, which decreases to 13.16% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 80.36 to suggest the stock is overbought.

The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 13.0% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 07, 2024 when The Benchmark Company upgraded the stock to “Buy” and issued a price target of $5.

Emergent Biosolutions Inc (EBS) stock is up 11.83% over the week and 98.63% over the past month. Its price is 81.25% year-to-date and -59.76% over the past year.

To reach the target analysts have set, the stock logically needs to grow 13.0 percent from here.

The company has a return on investment of -50.30% and return on equity of -60.56%. The beta has a value of 1.39. Price to book ratio is 0.34 and price to sales ratio is 0.19.